24Business
GC Cell runs the first dosage of the patient in the clinical test of phase 1 for GCC2005, the promising T’CELL lymphoma CD5 Car-Honna therapy
GC Cell runs the first dosage of the patient in the clinical test of phase 1 for GCC2005, the promising T’CELL lymphoma CD5 Car-Honna therapy
Source link
